New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
10:40 EDTCTAS, SNY, SFLY, WEN, AOLHigh option volume stocks: CTAS SNY SFLY WEN AOL
News For CTAS;SNY;SFLY;WEN;AOL From The Last 14 Days
Check below for free stories on CTAS;SNY;SFLY;WEN;AOL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 29, 2014
12:23 EDTSNYNovartis drug data to be presented this weekend
Subscribe for More Information
10:06 EDTSNYSanofi unit treatment of Fabry's disease granted orphan status
Subscribe for More Information
08:18 EDTSNYPerrigo among companies showing interest in Omega Pharma, Bloomberg says
Subscribe for More Information
August 26, 2014
06:33 EDTWENBurger King wants merger despite problems with dining combos, NY Times says
Subscribe for More Information
August 25, 2014
12:19 EDTSNYOn The Fly: Midday Wrap
Subscribe for More Information
11:48 EDTSNYSanofi and Regeneron co-host a conference call
Subscribe for More Information
10:40 EDTSNYBiotechs rise after InterMune acquired by Roche
Subscribe for More Information
August 22, 2014
12:39 EDTSNYThese five companies will benefit from increased ALS awareness, MarketWatch says
A recent surge in funding for Lou Gehrig's disease, or ALS, caused by the Ice Bucket challenge that is widespread on social media outlets, will benefit five pharmaceutical companies that are involved in the development of a cure for ALS, according to MarketWatch. The companies that are or have been involved in developing a treatment for ALS include Biogen Idec (BIIB), Avanir Pharmaceuticals (AVNR), Isis Pharmaceuticals (ISIS), Sanofi (SNY), and Bristol-Myers Squibb (BMY), MarketWatch added. Reference Link
August 21, 2014
05:42 EDTSNYIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
13:23 EDTSFLYShutterfly climbs higher after Hellman, others submit acquisition offers
Subscribe for More Information
12:37 EDTSFLYOn The Fly: Midday Wrap
Subscribe for More Information
11:47 EDTSFLYShutterfly more likely to be acquired by private equity firm, says RW Baird
Subscribe for More Information
10:40 EDTSFLYShutterfly calls active on PE firms bidding report
Shutterfly September 55 and 60 calls are active on total call volume of 3K contracts (1K puts) on Hellman & Friedman is one of the private equity firms that submitted takeover bids to acquire, Bloomberg reports. September call option implied volatility is at 38, December is at 32, January is at 27; compared to its 26-week average of 37 according to Track Data. Active call volume suggests traders taking positions for large price movement.
10:29 EDTSFLYHellman among PE firms bidding for Shutterfly, Bloomberg reports
Hellman & Friedman is one of the private equity firms that submitted takeover bids to acquire Shutterfly, Bloomberg reports, citing people with knowledge of the matter. Shutterfly could be valued at about $2B in a sale, but the company has received little interest from technology and Internet names, Bloomberg adds. Shares of online photo service rallied 3%, or $1.31, to $51.15 following the report. Reference Link
10:21 EDTSFLYShutterfly valued at about $2B by bidders, Bloomberg reports
10:20 EDTSFLYHellman & Friedman submitted bid to acquire Shutterfly, Bloomberg says
Subscribe for More Information
09:24 EDTAOLVringo intends to seek en banc review of decision in I/P Engine case
Vringo (VRNG) announced that its wholly-owned subsidiary I/P Engine, Inc. intends to file a petition with the United States Court of Appeals for the Federal Circuit seeking en banc review of the split appellate decision in its case against AOL (AOL), Google (GOOG) et al. that issued on August 15 and reversed the judgment of the United States District Court for the Eastern District of Virginia. Under the Federal Circuit's rules, I/P Engine's petition for en banc review is due on September 15. I/P Engine has filed an unopposed motion seeking a 30-day extension, which would make its petition due October 15. Upon receiving the requested extension, I/P Engine may file the petition on or anytime prior to October 15.
August 19, 2014
16:46 EDTSNYFDA approves Genzyme Cerdelga capsules
Subscribe for More Information
06:02 EDTWENTaco Bell introducing dollar menu, LA Times reports
Taco Bell (YUM) is introducing its new Dollar Cravings menu, which features 11 items, the LA Times reports. McDonald's (MCD) and Wendy's (WEN) both offer dollar menus. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use